Executive Order 14256 was signed by President Donald J. Trump on April 2, 2025. The Executive Order, Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports, was release by the following agency: Executive Office of the President